
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth
Keywords: استئوسارکوما; OS; osteosarcoma; miR or miRNA; microRNA; ncRNA; noncoding RNA; miR-34a; microRNA-34a; pre-miR-34a or mir-34a; pre-microRNA-34a; tRNA/mir-34a; transfer RNA fusion pre-miR-34a; CDK6; cyclin-dependent kinase 6; c-MET; hepatocyte growth factor receptor; SIRT